NCT02410122View on ClinicalTrials.gov

The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular Dystrophy

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Stargardt Disease
Trial Locations (5)

21287

Wilmer Eye Institute, Baltimore

53127

Universitäts-Augenklinik Bonn, Bonn

72076

Center for Opthalmic Research, University of Tuebingen, Tübingen

75231

Retina Foundation of the Southwest, Dallas

EC1V 2PD

Moorfields Eye Hospital, London

All Listed Sponsors
collaborator

The Shulsky Foundation

UNKNOWN

lead

Johns Hopkins University

OTHER

NCT02410122 - The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular Dystrophy | Biotech Hunter | Biotech Hunter